Hearing loss in patients with mucopolysaccharidosis II: Data from HOS – the Hunter Outcome Survey
Authors:
- Annerose KeilmannAKAnnerose Keilmann
- Todsaporn NakaratTNTodsaporn Nakarat
- Iain A. BruceIBIain A. Bruce
- David MolterDMDavid Molter
- Gunilla MalmGMGunilla Malm
- on behalf of the HOS InvestigatorsOIon behalf of the HOS Investigators
- 25 August 2011
- journal article
- Published by Wiley in Journal of Inherited Metabolic Disease
- Vol. 35 (2) , 343-353
Abstract
Background: Subjectively reported hearing loss is a common feature of mucopolysaccharidosis II (MPS II, Hunter syndrome). This study provides an epidemiological description of hearing loss and other otolaryngological manifestations reported by patients registered in the Hunter Outcome Survey (HOS), an international registry of patients with MPS II.Methods: Data about ear signs and symptoms were available for 554 of the 605 patients alive at HOS entry. The degree of hearing loss for 162 pure‐tone audiograms (PTAs) from 83 patients was classified by independent interpreters using both the age‐specific International Institute of Standardization (ISO) 7029 standard and the age‐independent World Health Organization (WHO) clinical guidelines. A linear regression analysis using cross‐sectional data was conducted to investigate the relationship between hearing loss and age.Results: The most prevalent otolaryngological manifestations and interventions reported were otitis (either acute otitis media or chronic otitis media [72%]), hearing loss (67%), insertion of ventilation tubes (50%), adenoidectomy (47%), and hearing aids (41%). According to the ISO standard, only one patient out of the 83 with audiogram data in HOS had normal hearing in both ears at all time points. According to the WHO classification, 16% had normal hearing; hearing loss was mild in 24%, moderate in 31%, severe in 22%, and profound in 7%. In the linear regression analysis, the hearing threshold in the cohort increased with age at an estimated rate of approximately 1 dB per year.Conclusions: Hearing impairment is common in MPS II. Early otolaryngological evaluation and intervention is recommended.Keywords
This publication has 26 references indexed in Scilit:
- Importance of surgical history in diagnosing mucopolysaccharidosis type II (Hunter syndrome): Data from the Hunter Outcome SurveyGenetics in Medicine, 2010
- Ear symptoms in children with Fabry disease: data from the Fabry Outcome SurveyJournal of Inherited Metabolic Disease, 2009
- Hearing Impairment in 2008: A compilation of available epidemiological studiesInternational Journal of Audiology, 2009
- The mucopolysaccharidoses: a heterogeneous group of disorders with variable pediatric presentationsThe Journal of Pediatrics, 2004
- Recommendations for the Description of Genetic and Audiological Data for Families with Nonsyndromic Hereditary Hearing ImpairmentAudiological Medicine, 2003
- From Screening to Early Identification and Intervention: Discovering Predictors to Successful Outcomes for Children With Significant Hearing LossJournal of Deaf Studies and Deaf Education, 2003
- Anaesthesia and mucopolysaccharidosesAnaesthesia, 1994
- Progress in Temporal Bone Histopathology II.Immuno-technology Applied to the Temporal boneActa Oto-Laryngologica, 1985
- Hearing Loss in Hunterʼs Syndrome-Mucopolysaccnaridosis IIEar & Hearing, 1984
- Psychosocial problems in Hunter's syndromeChild: Care, Health and Development, 1981